BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 19496639)

  • 1. Opportunities and considerations for pharmacist intervention in the management of the chronic hepatitis C patient.
    Walters-Smith N; Marshall SM
    J Manag Care Pharm; 2009 Jun; 15(5):417-9. PubMed ID: 19496639
    [No Abstract]   [Full Text] [Related]  

  • 2. The critical need for pharmacist involvement in the management of patients with hepatitis C.
    Spooner LM
    J Manag Care Pharm; 2009 Mar; 15(2):151-3. PubMed ID: 19236129
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of patients with HIV or hepatitis C by pharmacist clinicians in a patient-centered medical home.
    Ryan KL; Jakeman B; Conklin J; Pineda LJ; Deming P; Mercier RC
    Am J Health Syst Pharm; 2019 May; 76(11):821-828. PubMed ID: 31053839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integration and compensation of pharmacists into primary care medical groups.
    Woodhouse A; Clements E; Keedy C; Presnell A; Schnibben A
    J Am Pharm Assoc (2003); 2019; 59(6):886-890. PubMed ID: 31521587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ambulatory surgery centers: short-term stays mean long-term opportunities for pharmacists.
    Kaldy J
    Consult Pharm; 2012 Dec; 27(12):838-43. PubMed ID: 23229071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacist-run zoledronic acid clinic.
    Traina AN; Kane MP; Bakst G; Abelseth JM; Busch RS
    Am J Health Syst Pharm; 2011 Aug; 68(15):1399-403. PubMed ID: 21785027
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacist-managed headache clinic.
    Weitzel KW; Presley DN; Showalter ML; Seymour S; Waddell RF
    Am J Health Syst Pharm; 2004 Dec; 61(23):2548-50. PubMed ID: 15595231
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacist intervention in treatment of patients with genotype 1 chronic hepatitis C.
    Marino EL; Alvarez-Rubio L; Miro S; Modamio P; Banos F; Lastra CF; Alberdi-Leniz A
    J Manag Care Pharm; 2009 Mar; 15(2):147-50. PubMed ID: 19236128
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacist engagement within a hepatitis C ambulatory care clinic in the era of a treatment revolution.
    Gauthier TP; Moreira E; Chan C; Cabrera A; Toro M; Carrasquillo MZ; Corentin M; Sherman EM
    J Am Pharm Assoc (2003); 2016; 56(6):670-676. PubMed ID: 27667501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expanding opportunities through patient care: Pharmacists provide care...let me tell you about it.
    Brown L
    J Am Pharm Assoc (2003); 2015; 55(4):348-53. PubMed ID: 26161478
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacist-managed oral anticoagulation therapy in the community setting.
    Bouwmeester C; Chim C
    Consult Pharm; 2013 May; 28(5):280-94. PubMed ID: 23649677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of clinical pharmacist management of lipid-lowering therapy in a primary care setting.
    Till LT; Voris JC; Horst JB
    J Manag Care Pharm; 2003; 9(3):269-73. PubMed ID: 14613471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New York pharmacists push for CDTM.
    Traynor K
    Am J Health Syst Pharm; 2013 Nov; 70(21):1870, 1872. PubMed ID: 24128953
    [No Abstract]   [Full Text] [Related]  

  • 14. The first pharmacist-managed anticoagulation clinic under a collaborative practice agreement in Qatar: clinical and patient-oriented outcomes.
    Elewa HF; AbdelSamad O; Elmubark AE; Al-Taweel HM; Mohamed A; Kheir N; Mohamed Ibrahim MI; Awaisu A
    J Clin Pharm Ther; 2016 Aug; 41(4):403-8. PubMed ID: 27144477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Examination of MTM opportunities in pediatric behavioral health.
    Oji V
    J Manag Care Pharm; 2009 Jun; 15(5):420-2. PubMed ID: 19496640
    [No Abstract]   [Full Text] [Related]  

  • 16. COVID-19 and role of pharmacist in correctional facilities.
    Ta QTH; Nadeem MF; Matti N; Parveen S; Jawad M
    Res Social Adm Pharm; 2021 Jan; 17(1):2042-2043. PubMed ID: 32800459
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacists as mid-level practitioners/providers.
    Ross LA
    Ann Pharmacother; 2011 Jun; 45(6):810-2. PubMed ID: 21666080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacist-provided immunization compensation and recognition: white paper summarizing APhA/AMCP stakeholder meeting.
    Skelton JB; ;
    J Am Pharm Assoc (2003); 2011; 51(6):704-12. PubMed ID: 22068191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a pharmacist-managed hepatitis C care clinic.
    Smith JP; Dong MH; Kaunitz JD
    Am J Health Syst Pharm; 2007 Mar; 64(6):632-6. PubMed ID: 17353572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacist-provided services and community pharmacist integration into a patient-centered medical home: A qualitative study of primary care clinic staff perceptions.
    Bates KA; Stafford RA; Teeter BS; Diemer T; Thomas JL; Curran GM
    J Am Pharm Assoc (2003); 2019; 59(4S):S6-S11.e1. PubMed ID: 31101441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.